GLP‑1 weight‑loss drugs like Ozempic may help the heart heal after a heart attack, offering potential new treatment options, ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...

Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

Savannah Chrisley’s prescription weight loss website was flagged by the FDA over potentially misleading claims about GLP-1s.

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.